NCT04539886View on ClinicalTrials.gov

Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

February 2, 2021

Study Completion Date

November 18, 2021

Conditions
Skin LesionSkin AbnormalitiesSebaceous Hyperplasia
Interventions
DEVICE

CellFX System

CellFX System consists of a console combined with a handpiece and coupled with a sterile single patient-use treatment tip (1.5 x 1.5mm, 2.5 x 2.5mm, and 5.0 x 5.0mm)

DEVICE

Intralesional Electrodesiccation

Hyfrecator electrosurgical unit with a non-insulated needle-shaped electrode

Trial Locations (5)

28207

Dermatology, Laser & Vein Specialists of the Carolinas, PLLC, Charlotte

55424

Zel Skin & Laser Specialists, Edina

77056

Austin Institute for Clinical Research, Inc., Houston

78660

Austin Institute for Clinical Research, Inc., Pflugerville

85255

Investigate MD, LLC, Scottsdale

All Listed Sponsors
lead

Pulse Biosciences, Inc.

INDUSTRY

NCT04539886 - Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions | Biotech Hunter | Biotech Hunter